Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy, Safety & Tolerability of Ciclesonide 200mcg Spray 4 Weeks Treatment for Intermittent & Persistent Rhinitis (SISRIP)
This study has been completed.
Study NCT01369563   Information provided by Takeda Global Research & Development Center, Inc.

First Received on June 7, 2011.   Last Updated on September 14, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Perennial Rhinitis
Seasonal Rhinitis
Additional conditions recognized in this trial
Rhinitis
More general conditions related to this trial
Nose Diseases
Otorhinolaryngologic Diseases
Respiratory Tract Diseases
Respiratory Tract Infections
Additional drug interventions recognized in this trial
Ciclesonide
More general drug interventions related to this trial
Anti-Allergic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Takeda México S.A. de C.V.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services